Literature DB >> 16061652

Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1.

Yehudit Birger1, Frédéric Catez, Takashi Furusawa, Jae-Hwan Lim, Marta Prymakowska-Bosak, Katherine L West, Yuri V Postnikov, Diana C Haines, Michael Bustin.   

Abstract

We report that loss of HMGN1, a nucleosome-binding protein that alters the compaction of the chromatin fiber, increases the cellular sensitivity to ionizing radiation and the tumor burden of mice. The mortality and tumor burden of ionizing radiation-treated Hmgn1-/- mice is higher than that of their Hmgn1+/+ littermates. Hmgn1-/- fibroblasts have an altered G2-M checkpoint activation and are hypersensitive to ionizing radiation. The ionizing radiation hypersensitivity and the aberrant G2-M checkpoint activation of Hmgn1-/- fibroblasts can be reverted by transfections with plasmids expressing wild-type HMGN1, but not with plasmids expressing mutant HMGN proteins that do not bind to chromatin. Transformed Hmgn1-/- fibroblasts grow in soft agar and produce tumors in nude mice with a significantly higher efficiency than Hmgn1+/+ fibroblasts, suggesting that loss of HMGN1 protein disrupts cellular events controlling proliferation and growth. Hmgn1-/- mice have a higher incidence of multiple malignant tumors and metastases than their Hmgn1+/+ littermates. We suggest that HMGN1 optimizes the cellular response to ionizing radiation and to other tumorigenic events; therefore, loss of this protein increases the tumor burden in mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061652      PMCID: PMC3714215          DOI: 10.1158/0008-5472.CAN-05-0310

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

Review 1.  Light and dark in chromatin repair: repair of UV-induced DNA lesions by photolyase and nucleotide excision repair.

Authors:  F Thoma
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

2.  High mobility of proteins in the mammalian cell nucleus.

Authors:  R D Phair; T Misteli
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

Review 3.  The DNA damage response: putting checkpoints in perspective.

Authors:  B B Zhou; S J Elledge
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

Review 4.  When repair meets chromatin. First in series on chromatin dynamics.

Authors:  Catherine M Green; Geneviève Almouzni
Journal:  EMBO Rep       Date:  2002-01       Impact factor: 8.807

5.  Chromatin unfolding and activation by HMGN(*) chromosomal proteins.

Authors:  M Bustin
Journal:  Trends Biochem Sci       Date:  2001-07       Impact factor: 13.807

6.  Mitotic phosphorylation prevents the binding of HMGN proteins to chromatin.

Authors:  M Prymakowska-Bosak; T Misteli; J E Herrera; H Shirakawa; Y Birger; S Garfield; M Bustin
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 7.  Histone H2A variants H2AX and H2AZ.

Authors:  Christophe Redon; Duane Pilch; Emmy Rogakou; Olga Sedelnikova; Kenneth Newrock; William Bonner
Journal:  Curr Opin Genet Dev       Date:  2002-04       Impact factor: 5.578

8.  Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment.

Authors:  J M Espinosa; B M Emerson
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

Review 9.  SWI/SNF chromatin remodeling and cancer.

Authors:  Agnès Klochendler-Yeivin; Christian Muchardt; Moshe Yaniv
Journal:  Curr Opin Genet Dev       Date:  2002-02       Impact factor: 5.578

Review 10.  Histone deacetylase inhibitors as new cancer drugs.

Authors:  P A Marks; V M Richon; R Breslow; R A Rifkind
Journal:  Curr Opin Oncol       Date:  2001-11       Impact factor: 3.645

View more
  48 in total

1.  Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells.

Authors:  Ning Jiang; Li-Qun Zhou; Xiao-Yu Zhang
Journal:  Asian J Androl       Date:  2010-06-07       Impact factor: 3.285

2.  Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement.

Authors:  Maisa Yoshimoto; Anthony M Joshua; Susan Chilton-Macneill; Jane Bayani; Shamini Selvarajah; Andrew J Evans; Maria Zielenska; Jeremy A Squire
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

Review 3.  HMG chromosomal proteins in development and disease.

Authors:  Robert Hock; Takashi Furusawa; Tetsuya Ueda; Michael Bustin
Journal:  Trends Cell Biol       Date:  2006-12-13       Impact factor: 20.808

4.  Delineation of the protein module that anchors HMGN proteins to nucleosomes in the chromatin of living cells.

Authors:  Tetsuya Ueda; Frédéric Catez; Gabi Gerlitz; Michael Bustin
Journal:  Mol Cell Biol       Date:  2008-02-25       Impact factor: 4.272

5.  Distinct properties of human HMGN5 reveal a rapidly evolving but functionally conserved nucleosome binding protein.

Authors:  Cedric Malicet; Mark Rochman; Yuri Postnikov; Michael Bustin
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

6.  Elevated HMGN4 expression potentiates thyroid tumorigenesis.

Authors:  Jamie Kugler; Yuri V Postnikov; Takashi Furusawa; Shioko Kimura; Michael Bustin
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

Review 7.  HMGNs, DNA repair and cancer.

Authors:  Gabi Gerlitz
Journal:  Biochim Biophys Acta       Date:  2009-12-08

8.  The nucleosome binding protein HMGN3 is expressed in pancreatic alpha-cells and affects plasma glucagon levels in mice.

Authors:  Toshihiro Kurahashi; Takashi Furusawa; Tetsuya Ueda; Michael Bustin
Journal:  J Cell Biochem       Date:  2010-01-01       Impact factor: 4.429

9.  Loss of the nucleosome-binding protein HMGN1 affects the rate of N-nitrosodiethylamine-induced hepatocarcinogenesis in mice.

Authors:  Yuri V Postnikov; Takashi Furusawa; Diana C Haines; Valentina M Factor; Michael Bustin
Journal:  Mol Cancer Res       Date:  2013-12-02       Impact factor: 5.852

10.  Activation of ATM depends on chromatin interactions occurring before induction of DNA damage.

Authors:  Yong-Chul Kim; Gabi Gerlitz; Takashi Furusawa; Frédéric Catez; Andre Nussenzweig; Kyu-Seon Oh; Kenneth H Kraemer; Yosef Shiloh; Michael Bustin
Journal:  Nat Cell Biol       Date:  2008-12-14       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.